Analyst consensus rating
Crescent Capital BDC Analyst Rating: Buy
CCAP is rated Buy by 7 analysts with a $12.64 target. As of 2026-08-21.
Direct answer
Crescent Capital BDC's consensus rating is Buy.
7 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $12.64.
Forecast evidence checked August 21, 2026.
Get free Crescent Capital BDC email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $10.68
- Average price target
- $12.64
- High price target
- $14.00
- Low price target
- $11.00
- Low target gap
- +3%
- Target upside
- +18.4%
- High target gap
- +31.1%
- Target range width
- 28.1%
- Consensus rating
- Buy
- Analysts
- 7
- Evidence date
- August 21, 2026
- Valid through
- August 28, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Crescent Capital BDC?
Crescent Capital BDC has a verified Buy consensus. The same dataset has an average price target of $12.64.
How far are Crescent Capital BDC's low and high targets from the recorded price?
The low target implies +3%, while the high target implies +31.1%.
How many analysts are included in Crescent Capital BDC's consensus?
The verified consensus includes 7 analysts.
How is Crescent Capital BDC's target upside or downside calculated?
The average target of $12.64 is divided by the recorded price of $10.68, then one is subtracted to produce +18.4%. This does not guarantee a future return.
When was Crescent Capital BDC's analyst forecast verified?
The data was verified on 2026-08-21. The dataset is valid through 2026-08-28.